US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.07

+0.07000.30%

Post-market: 23.120.0550+0.24%16:10 EDT

Volume:2K

Turnover:56.63K

Market Cap:4.61M

PE:- -

High:23.28

Open:23.00

Low:23.00

Close:23.00

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:15.02

T/O Rate:1.23%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

India's Economy Poised to Approach 8% Growth, Says PM Modi's Top Aide

ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases

JSW Energy Subsidiary JSW Renew Energy Three Gets IND A/Stable Rating

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

India Ratings Affirms Sona BLW Precision Forgings at IND AA+ with Stable Outlook

NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum

India Ratings Upgrades Aye Finance to ‘IND A+’ on Stronger Capital and Profitability

NeOnc Wins Abu Dhabi IND Clearance for NEO100

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Ab&B Bio-Tech Wins Dual China-U.S. IND Nod for First mRNA Mpox Vaccine

AB&B BIO-TECH-B's mRNA Monkeypox Vaccine Candidate Receives IND Approval from China's CDE

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

INNOGEN-B Shares Surge Over 17% Following NMPA Approval for Adolescent Weight Loss Trial of Esupaglutide α

India Ratings Affirms IND AA/Stable for JSW Energy Barmer Loans

Press Release: SL Science Holding Limited Reports Full Year 2025 Financial Results

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Starbucks Intensifies Focus on India with Ambitious Store Expansion Plan

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IND/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.065,"timestamp":1787601600000,"preClose":22.995,"halted":0,"volume":2451,"hourTrading":{"tag":"盘后","latestPrice":23.12,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204726,"change":0.055,"changeRate":0.002385,"amplitude":0},"delay":0,"changeRate":0.0030441400304414127,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Closed","change":0.07,"latestTime":"08-24 16:00:00 EDT","open":23,"high":23.28,"low":23,"amount":56631,"amplitude":0.012177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":22.995,"sharesOutstanding":200001,"nav":23.031,"aum":4606217.85,"dividendRate":0.003408,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":23.1,"preClose":22.995,"latestTime":"09:29 EDT","volume":206,"amount":4758.869860000001,"timestamp":1787578199043,"change":0.105,"changeRate":0.004566,"amplitude":0.004784},"postHourTrading":{"tag":"盘后","latestPrice":23.12,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204726,"change":0.055,"changeRate":0.002385,"amplitude":0},"volumeRatio":15.018366},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.018366,"shares":200001,"dividePrice":0.0786,"high":23.28,"amplitude":0.012177,"preClose":22.995,"low":23,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.065,"eps":0,"divideRate":0.003408,"volume":2451,"delay":0,"ttmEps":0,"open":23,"prevYearClose":24.78,"prevWeekClose":22.995,"prevMonthClose":22.885,"prevQuarterClose":22.88,"fiveDayClose":23.005,"twentyDayClose":22.495,"sixtyDayClose":22.475},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199283809","title":"India's Economy Poised to Approach 8% Growth, Says PM Modi's Top Aide","url":"https://stock-news.laohu8.com/highlight/detail?id=1199283809","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199283809?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:22","pubTimestamp":1782714152,"startTime":"0","endTime":"0","summary":"India's economy has the potential to once again approach an 8% annual growth rate if no major fresh global conflicts erupt, according to a top aide to Prime Minister Narendra Modi.Shaktikanta Das,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INQQ","NDIA","NFTY","SMIN","INDE","INCO","IND","INDL","IMVP","EPI","FLIN","PIN","BK4523","BK4585","BK4588","GLIN","INDA","EMXC","INDY","SCIN","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139407184","title":"ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=1139407184","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139407184?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:22","pubTimestamp":1782714151,"startTime":"0","endTime":"0","summary":"Shares of ASCLETIS-B (HKEX: 01672) have risen more than 7%. At the time of writing, the stock is up 7.2%, trading at HK$10.42 with a turnover of HK$13.24 million. The company has announced that it...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","BK1515","BK1191","BK4104","GIC","IND","BK4585","LABU","VXUS","BK1161","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646908365","title":"JSW Energy Subsidiary JSW Renew Energy Three Gets IND A/Stable Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2646908365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646908365?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:22","pubTimestamp":1782483736,"startTime":"0","endTime":"0","summary":"JSW Energy Limited ( ($IN:JSWENERGY) ) just unveiled an announcement. India Ratings and Research has assigned an “IND A/Stable” credit rating to th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jsw-energy-subsidiary-jsw-renew-energy-three-gets-ind-a-stable-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jsw-energy-subsidiary-jsw-renew-energy-three-gets-ind-a-stable-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646628385","title":"NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2646628385","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646628385?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417660,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., June  25, 2026  (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/25/3317921/0/en/NRx-Pharmaceuticals-Responds-to-Recent-Public-Statements-Regarding-Kadima-Dispute.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMS","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646805262","title":"India Ratings Affirms Sona BLW Precision Forgings at IND AA+ with Stable Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2646805262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646805262?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:24","pubTimestamp":1782393853,"startTime":"0","endTime":"0","summary":"An announcement from Sona BLW Precision Forgings Ltd. ( ($IN:SONACOMS) ) is now available. India Ratings & Research has affirmed Sona BLW Precision...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-sona-blw-precision-forgings-at-ind-aa-with-stable-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-sona-blw-precision-forgings-at-ind-aa-with-stable-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","IND","BLW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645813606","title":"NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2645813606","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645813606?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:45","pubTimestamp":1782305100,"startTime":"0","endTime":"0","summary":"NTHI Continues to Build Regulatory Momentum prior to Upcoming Phase 2 DataDENVER, June  24, 2026  (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is entering one ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/24/3316856/0/en/NeOnc-Ignites-Explosive-Summer-4-New-Research-Reports-UAE-Dubai-Drug-Approval-Fuel-Breakout-Momentum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4007","NTHI","UAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645861587","title":"India Ratings Upgrades Aye Finance to ‘IND A+’ on Stronger Capital and Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2645861587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645861587?lang=en_us&edition=fundamental","pubTime":"2026-06-24 12:05","pubTimestamp":1782273947,"startTime":"0","endTime":"0","summary":"Aye Finance Limited ( ($IN:AYE) ) has provided an update. India Ratings and Research has upgraded Aye Finance Limited’s issuer, non-convertible deb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-aye-finance-to-ind-a-on-stronger-capital-and-profitability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-aye-finance-to-ind-a-on-stronger-capital-and-profitability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645852705","title":"NeOnc Wins Abu Dhabi IND Clearance for NEO100","url":"https://stock-news.laohu8.com/highlight/detail?id=2645852705","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645852705?lang=en_us&edition=fundamental","pubTime":"2026-06-24 06:39","pubTimestamp":1782254374,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings, Inc. ( ($NTHI) ) just unveiled an update. On June 23, 2026, NeOnc Technologies announced that Abu Dhabi’s Department o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neonc-wins-abu-dhabi-ind-clearance-for-neo100?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neonc-wins-abu-dhabi-ind-clearance-for-neo100?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645397028","title":"NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2645397028","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645397028?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:00","pubTimestamp":1782219600,"startTime":"0","endTime":"0","summary":"Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric studies Extends NeOnc’s UAE footprint beyond NEO212 and complements ongoing U.S. development, where ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/23/3316012/0/en/NeOnc-Technologies-Receives-UAE-IND-Approval-for-NEO100-Expanding-Global-Development-Ahead-of-Anticipated-Phase-2-Data-Milestone.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","UAE","CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645383673","title":"Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2645383673","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645383673?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:17","pubTimestamp":1782217020,"startTime":"0","endTime":"0","summary":"Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling development program SARASOTA, FLA., June  23, 2026  (GLOBE NEWSWIRE) --  Silo Pharma (Nasdaq: SILO) (“S","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/23/3315946/0/en/Silo-Pharma-Reports-Positive-Stability-Data-for-SPC-15-PTSD-Treatment-Advancing-Program-Toward-First-in-Human-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668461.USD","BK4006","IE00BFXG1179.USD","LU0267386448.USD","SPC","LU2237443622.USD","CNS","IE00BKVL7J92.USD","LU1363072403.SGD","BK4135","IE00B1BXHZ80.USD","LU2237443549.SGD","IND","LU2237443465.HKD","IE00BZ1G4Q59.USD","LU2237443978.SGD","LU2237443895.HKD","LU0149725797.USD","LU2237443382.USD","IE00BHPRN162.USD","LU0971096721.USD","CMC","LU0882574139.USD","LU0170899867.USD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645838226","title":"Ab&B Bio-Tech Wins Dual China-U.S. IND Nod for First mRNA Mpox Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2645838226","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645838226?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:00","pubTimestamp":1782212450,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS Class H ( ($HK:2627) ) has issued an announcement. Ab&B Bio-Tech CO., LTD. JS, a China-based vaccine developer, has secu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abb-bio-tech-wins-dual-china-u-s-ind-nod-for-first-mrna-mpox-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abb-bio-tech-wins-dual-china-u-s-ind-nod-for-first-mrna-mpox-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121897103","title":"AB&B BIO-TECH-B's mRNA Monkeypox Vaccine Candidate Receives IND Approval from China's CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1121897103","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121897103?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:12","pubTimestamp":1782209561,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (ASX: 02627) has announced that, following the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA), the Center for Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","159646","IND","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157125267","title":"ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=1157125267","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157125267?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:10","pubTimestamp":1782209421,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced the receipt of an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) for the Phase I clinical study of its drug candidate,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","BK4144","01477","BK4588","LABU","01672","GIPR","BK1574","BK1515","BK1191","BK4590","IND","GLP","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123803607","title":"INNOGEN-B Shares Surge Over 17% Following NMPA Approval for Adolescent Weight Loss Trial of Esupaglutide α","url":"https://stock-news.laohu8.com/highlight/detail?id=1123803607","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123803607?lang=en_us&edition=fundamental","pubTime":"2026-06-23 09:58","pubTimestamp":1782179905,"startTime":"0","endTime":"0","summary":"Shares of INNOGEN-B (02591) are currently trading sharply higher, with gains exceeding 17%. At the time of writing, the stock is up 14.03% to HK$8.94, with a trading turnover of HK$45.71 million.The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IND","BK4585","VXUS","BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644050436","title":"India Ratings Affirms IND AA/Stable for JSW Energy Barmer Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2644050436","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644050436?lang=en_us&edition=fundamental","pubTime":"2026-06-19 23:47","pubTimestamp":1781884031,"startTime":"0","endTime":"0","summary":"An update from JSW Energy Limited ( ($IN:JSWENERGY) ) is now available. India Ratings and Research has affirmed an “IND AA/Stable” credit rating fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-ind-aa-stable-for-jsw-energy-barmer-loans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-ind-aa-stable-for-jsw-energy-barmer-loans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AA","MNDmain","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644390000","title":"Press Release: SL Science Holding Limited Reports Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2644390000","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644390000?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:13","pubTimestamp":1781817180,"startTime":"0","endTime":"0","summary":"Taipei, TAIWAN, June 18, 2026  --  SL Science Holding Limited  , a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.\"Looking ahead, with the vision of establishing one of the leading allogeneic Gamma Delta T cell platforms in Asia with global commercialization potential, our focus is squarely on regulatory preparedness and preclinical execution. For our CD-19 Armed-T blood cancer program, we are actively addressing the FDA's initial feedback by conducting additional nonclinical validation and manufacturing scale-ups, aiming for a Pre-Investigational New Drug  meeting and formal IND submission in the first quarter of 2027. Concurrently, our Unmodified GDT cell platform is progressing through technical transfers to an FDA-compliant contract development and manufacturing organization . Unlike traditional autologous therapies, our GDT cell approach is de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLBT","CDMO","BK4139","GDT","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644085147","title":"Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644085147","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644085147?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:00","pubTimestamp":1781784000,"startTime":"0","endTime":"0","summary":"Proceeds from transaction to support advancement of Denali’s broad TransportVehicle-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseasesDenali was awarded Priority","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/18/3314101/0/en/Denali-Therapeutics-Enters-Agreement-to-Sell-Rare-Pediatric-Disease-Priority-Review-Voucher-for-195-Million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TV","BK4539","BK4139","LENZ","IND","BK4100","BK4585","ETV","BK4115","BBB","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138086374","title":"Starbucks Intensifies Focus on India with Ambitious Store Expansion Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1138086374","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138086374?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:00","pubTimestamp":1781766040,"startTime":"0","endTime":"0","summary":"Despite facing pressures to adjust its global operations, Starbucks (SBUX.US) is accelerating its push into the Indian market. The coffee giant's joint venture with India's Tata Group, Tata Starbucks...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4523","SMIN","FLIN","SBUX","BK4504","INDA","INCO","NDIA","IE00B3T34201.USD","INDL","EPI","BK4535","BK4585","PIN","INQQ","LU0823411888.USD","BK4610","SCIN","LU0882574139.USD","BK4588","NFTY","INDE","SBU","GLIN","IND","INDY","BK4209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749918","title":"Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749918","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749918?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:47","pubTimestamp":1781700420,"startTime":"0","endTime":"0","summary":"Lead Cell Therapy Demonstrated Complete Tumor Clearance and 100% Long-Term Survival in Preclinical Ovarian Cancer Models; Multiple Regulatory, Manufacturing and Clinical Catalysts Expected Through 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/17/3313445/0/en/Ernexa-Therapeutics-Positioned-to-Become-a-Clinical-Stage-Biotechnology-Company-as-ERNA-101-On-Track-for-Planned-Q3-2026-IND-Submission-and-First-in-Human-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643750538","title":"NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750538","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643750538?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:00","pubTimestamp":1781614800,"startTime":"0","endTime":"0","summary":"Clearance enables Phase 2 evaluation of NEO212, the Company’s oral perillyl alcohol-temozolomide conjugate, in the United Arab Emirates Follows completion of Phase 1 dose escalation and selection of 6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312654/0/en/NeOnc-Technologies-Secures-UAE-IND-Approval-for-NEO212-Following-Successful-Phase-1-Completion-Advancing-Toward-Global-Phase-2-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","IND","UAE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}